Zenith Drugs Limited (NSE:ZENITHDRUG)
69.85
+0.95 (1.38%)
At close: Sep 11, 2025
Zenith Drugs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
Net Income | 71.61 | 95.93 | 48.81 | 31.38 | 30.29 | Upgrade |
Depreciation & Amortization | 29.66 | 13.03 | 13.05 | 13.26 | 12.16 | Upgrade |
Loss (Gain) From Sale of Assets | -2.46 | - | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -0.46 | - | - | - | - | Upgrade |
Other Operating Activities | 3 | 28.13 | 22.57 | 20.87 | 15.56 | Upgrade |
Change in Accounts Receivable | 68.17 | -180.83 | -172.43 | -86.86 | 20.52 | Upgrade |
Change in Inventory | -138.54 | -20.85 | -115.42 | -52.99 | -24.69 | Upgrade |
Change in Accounts Payable | -44.9 | -58.38 | 172.87 | 144.18 | -27.39 | Upgrade |
Change in Other Net Operating Assets | -40.74 | -7.13 | -17.16 | -18.3 | -18.89 | Upgrade |
Operating Cash Flow | -54.66 | -130.1 | -47.72 | 51.53 | 7.57 | Upgrade |
Operating Cash Flow Growth | - | - | - | 580.91% | -78.23% | Upgrade |
Capital Expenditures | -313.08 | -53.3 | -55.71 | -52.42 | -14.28 | Upgrade |
Sale of Property, Plant & Equipment | - | 4.85 | 56.77 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -1.71 | - | - | - | - | Upgrade |
Investment in Securities | 0.71 | -41.01 | -3.75 | - | - | Upgrade |
Other Investing Activities | - | 0 | -0 | -0 | - | Upgrade |
Investing Cash Flow | -314.07 | -89.46 | -2.69 | -52.42 | -14.28 | Upgrade |
Short-Term Debt Issued | 196.92 | - | 85.1 | 10.32 | 57.55 | Upgrade |
Long-Term Debt Issued | 87 | 1.96 | - | 22.96 | - | Upgrade |
Total Debt Issued | 283.93 | 1.96 | 85.1 | 33.28 | 57.55 | Upgrade |
Short-Term Debt Repaid | - | -16.69 | - | - | - | Upgrade |
Long-Term Debt Repaid | - | - | -12.08 | - | -23.48 | Upgrade |
Total Debt Repaid | - | -16.69 | -12.08 | - | -23.48 | Upgrade |
Net Debt Issued (Repaid) | 283.93 | -14.73 | 73.02 | 33.28 | 34.08 | Upgrade |
Issuance of Common Stock | - | 349.5 | - | - | - | Upgrade |
Other Financing Activities | 0 | -29.97 | -23.09 | -20.86 | -13.24 | Upgrade |
Financing Cash Flow | 283.93 | 304.79 | 49.94 | 12.42 | 20.84 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | Upgrade |
Net Cash Flow | -84.8 | 85.24 | -0.48 | 11.53 | 14.12 | Upgrade |
Free Cash Flow | -367.74 | -183.4 | -103.43 | -0.89 | -6.72 | Upgrade |
Free Cash Flow Margin | -27.58% | -13.93% | -9.03% | -0.10% | -0.92% | Upgrade |
Free Cash Flow Per Share | -21.47 | -10.70 | -8.62 | -0.07 | -0.56 | Upgrade |
Cash Interest Paid | 37.11 | 20 | 23.09 | 18.18 | 11.46 | Upgrade |
Cash Income Tax Paid | 20.46 | 40.34 | 18.28 | 13.22 | 13.73 | Upgrade |
Levered Free Cash Flow | -391.25 | -216.08 | -161.57 | -25.68 | -15.63 | Upgrade |
Unlevered Free Cash Flow | -368.06 | -203.57 | -154.4 | -14.32 | -8.46 | Upgrade |
Change in Working Capital | -156.01 | -267.19 | -132.15 | -13.98 | -50.45 | Upgrade |
Updated May 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.